Methods of identifying and treating individuals exhibiting mutant SRC kinase polypeptides

Details for Australian Patent Application No. 2006270187 (hide)

Owner Bristol-Myers Squibb Company

Inventors Lee, Francis Y.

Agent A J Park

Pub. Number AU-A-2006270187

PCT Pub. Number WO2007/011765

Priority 60/699,675 15.07.05 US

Filing date 13 July 2006

Wipo publication date 25 January 2007

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/011765 Priority application(s): WO2007/011765

9 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006270193-Yield increase in plants overexpressing the MTP genes

2006270184-JNK inhibitors for the treatment of endometreosis